FLFrançois Leulier

François Leulier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


François Leulier has a total of 264 co-authors. Here are the top co-authors by number of shared publications:

  • Benjamin Gillet

    Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieur de Lyon, CNRS UMR 5242, Université Claude Bernard Lyon 1 , 46 allée d'Italie, 69007 Lyon

    11 shared publications
  • Pauline Joncour

    Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5242, Université Claude Bernard Lyon 1, 69364 Lyon Cedex 07, France

    11 shared publications
  • Hugo Gervais

    Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5242, Université Claude Bernard Lyon 1, 69364 Lyon Cedex 07, France

    9 shared publications
  • Longwei Bai

    Affiliation Centre National de la Recherche Scientifique, Ecole Normale Supérieure de Lyon, Institut de Génomique Fonctionnelle de Lyon UMR5242, Lyon, France

    9 shared publications
  • Maria Elena Martino

    Department of Comparative Biomedicine and Food Science, University of Padova

    9 shared publications
  • Martin Schwarzer

    Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences

    9 shared publications

Latest Publications

  • Open Access

    Host-triggered prophage induction drives Lactiplantibacillus plantarum symbiosis through bacterial lysis

    by Chenxu Zhu, Sylvie Manuse, Quentin Perrier, Subhasree Venkatasubramaniyan, Houssam Akherraz, Norbert Lodej, Cathy I. Ramos, Meiling Zhang, Christophe Grangeasse, Agnieszka Razim, et al.


  • Sexual dimorphisms in juvenile development under nutritionnal stress

    by Amélie Joly, François Leulier

    Nutrition is a fundamental regulator of juvenile development. The persistently high global prevalence of childhood undernutrition and consequent stunting underscores the urgent need to better understand how nutritional status shapes developmental trajectories. Biological sex has recently emerged as a key risk factor for stunting, with boys consistently exhibiting greater vulnerability. This review examines the biological basis of sex differences in physiological adaptation to nutritional stress, focusing specifically on dietary protein deficiency during the juvenile period. Two critical developmental processes display pronounced sexual dimorphism under protein restriction: linear growth and reproductive maturation. Evidence from both preclinical and clinical studies indicates that juvenile protein restriction differentially affects these processes in males and females, highlighting the necessity of considering sex as a biological variable in experimental design and data interpretation. Shared endocrine signals, including Fibroblast Growth Factor 21, may contribute to these sex-specific adaptive responses. Further elucidating the nutritional, endocrine and metabolic mechanisms underlying sexually dimorphic outcomes of juvenile development is essential for enhancing the mechanistic value and translational relevance of preclinical and clinical research.

  • Open Access

    A nutrient-sensitive enterokine coordinates developmental plasticity through inter-organ signaling

    by Longwei Bai, Jacques Montagne, Cathy Isaura Ramos, François Leulier

    Animal survival in fluctuating environments depends on the ability to modulate their developmental pace in response to nutrient availability, a phenomenon known as developmental plasticity. In Drosophila larvae, we uncover a critical endocrine mechanism that coordinates this process under conditions of amino acid restriction. We identify the peptide hormone Limostatin as an enterokine, produced by a small population of larval midgut enteroendocrine cells, that acts systemically to inhibit the expression and release of dIlp2, a major insulin-like peptide controlling developmental progression. Limostatin expression and secretion by enteroendocrine cells is triggered by reduced amino acid availability through an inter-organ relay involving the fat body and neuroendocrine insulin-producing cells in the brain. In turn, Limostatin participates in a feedback control loop that slows down developmental progression once systemic nutrient shortage is sensed. This bidirectional gut–brain axis enables larvae to preserve viability under nutritional stress. Our findings define the larval gut as a nutrient-sensitive endocrine organ and position Limostatin as a key regulator of developmental plasticity. Our work expands the concept of decretins to include developmental pace control, suggesting that enterokines that regulate IGF signaling, rather than insulin release per se, may represent an evolutionarily conserved or convergent strategy in regulating developmental plasticity.


  • Open Access

    OrganScaleR: An Open Shiny Tool for Principled Organ-Weight Inference in Mouse Physiology

    by Lucas Rebiffe, Laurent Gilquin, Francois Leulier, Filipe De Vadder

    Background: Organ weights are often divided by body weight to report "relative" organ size. Yet ratios usually stay size-dependent and become misleading. We built a simple decision path for size adjustment and wrapped it in a Shiny application so physiologists can get correct answers without coding. Methods: We reused liver and body-weight data from a mouse nutrition study for confirmatory examples in two common cases: when diet groups shared a wide body-size range, and when diet produced much smaller animals with little overlap. We compared liver-to-body-weight ratios with size-adjusted regression when the body-size overlap allowed comparisons, and with causal Bayesian mediation when it did not. The full workflow was implemented in OrganScaleR, a guided R Shiny application. Results: The ratio-normalized organ weight is still associated with body weight, leading to misleading comparisons. Modeling liver weight against body weight gave more cautious, size-adjusted effects when groups shared a common size range. When diets shifted body size strongly and overlap was limited, causal mediation showed that most organ differences followed the change in body weight rather than an organ-specific action. Simulations confirmed that ratios can generate false positives and biased estimates under allometric scaling, while model-based approaches remained reliable. OrganScaleR implements this decision workflow in a guided Shiny application that returns interpretable effects. Conclusions: OrganScaleR selects scale, enforces common support, and routes the analysis to size-adjusted ANCOVA or causal Bayesian mediation depending on body-weight overlap. It reports adjusted effects in original units through a point-and-click workflow, removing the statistical barrier to abandoning ratio normalization.


  • Gut commensal Bacteroides faecichinchillae, a potential novel candidate of next-generation probiotics targeting type 2 diabetes

    by M. Godet, E. Delmas, C. GérArd, E. Meugnier, A. Bravard, C. Pinteur, N. Vega, N. Bendridi, D. Cheillan, S. Fourati, et al.

    The implication of gut microbiota in the pathophysiology of type 2 diabetes, one of the major health concerns worldwide, has demonstrated the benefits of using probiotics to improve dysbiosis. Facing the lack of defined research strategy to found and qualify bacterial with real antidiabetic activity, we have developed a program to identify, select and validate novel strains able to improve metabolic alterations in type 2 diabetes. Among potential candidates, we identified Bacteroides faecichinchillae (named BAfa hereafter), and the present work presents the validation of the antidiabetic potential of the ST37 (DSMZ 26883) BAfa strain in mice fed a high-fat high-sucrose (HFS) diet for 10 weeks followed by 4 weeks of treatment. Daily gavage with live, but not heat inactivated, BAfa improved glucose tolerance, fasting hyperinsulinemia and liver triglyceride content in HFS fed mice. Furthermore, these beneficial effects were retained after lyophilization. Using this preclinical model, we characterised BAfa mechanism of action, showing that four weeks of treatment was associated with reduced hepatic accumulation of ceramides, key actors of insulin resistance. The underlying mechanism could be related to BAfa-induced changes in the intestinal bile acid profile and inhibition of the Fxr-Fgf15 pathway in the ileum. BAfa supplementation during 4 weeks in HFS fed mice was also associated with mild modifications of gut microbiota composition, with the upregulation of several species known for their beneficial metabolic actions (such as Lactobacillus johnsonii , Limosilactobacillus reutei , Roseburia , Turicimonas muris , Phocaeicola dorei or Akkermansia muciniphila ) and for being up-regulated during metformin treatment. Altogether, these data indicate that BAfa and related B. faecichinchillae strains could be considered for developing next-generation probiotics to treat type 2 diabetes, potentially in combination with the anti-diabetic drug metformin.

  • Open Access

    A DltE–DltD–DltX interaction network regulates lipoteichoic acid D-alanylation in Lactiplantibacillus plantarum and symbiotic drosophila growth promotion

    by Renata C. Matos, Nikos Nikolopoulos, Quentin Perrier, Xavier Robert, Virginie Gueguen-Chaignon, Hiroto Hirayama, François Leulier, Christophe Grangeasse, Yann Guerardel, Stéphanie Ravaud

    D-alanylation of teichoic acids is a widespread modification of Gram-positive bacterial cell envelopes that modulates resistance to environmental stresses and host interactions. Although the cytosolic steps of this pathway are well characterized, the extracellular reactions responsible for transferring D-alanine onto teichoic acids remain poorly understood. Here we investigate the role of DltD in the commensal bacterium Lactiplantibacillus plantarum . We determined the 2.3 Å crystal structure of the extracellular catalytic domain of DltD, which adopts an SGNH-hydrolase fold with a conserved Ser–His–Asp catalytic triad. Docking analyses with lipoteichoic acids (LTA) fragments suggest that the glycerol-phosphate backbone of LTA is accommodated along a surface groove leading to the catalytic serine, with conserved residues contributing to substrate positioning. Biochemical measurements further reveal direct interactions between DltD, the acyl-carrier protein DltX, and the LTA esterase DltE. The conserved C-terminal motif of DltX binds DltD and is required for efficient D-alanylation and for L. plantarum –mediated promotion of Drosophila juvenile growth. Together, these findings support a DltX-dependent acyl-transfer mechanism and reveal an interaction network that coordinates LTA D-alanylation in a symbiotic bacterium.


  • Ecdysone-mediated intestinal growth contributes to microbiota-driven developmental plasticity under malnutrition

    by Longwei Bai, Stéphanie Bellemin, Elodie Guillemot, Maura Strigini, Benjamin Gillet, Cathy Isaura Ramos, François Leulier

    Organ and systemic growth must remain coordinated during development, even under nutritional stress. In Drosophila larvae, the intestinal microbiota contributes to this coordination by promoting growth and maturation under chronic undernutrition. Using gnotobiotic models, we show that association with Lactiplantibacillus plantarum (Lp) selectively enhances midgut growth relative to other organs, providing an adaptive mechanism that buffers the impact of dietary restriction. Transcriptomic profiling of larval midguts revealed a strong Ecdysone (Ecd) signaling signature upon Lp association. Functional analyses showed that local conversion of Ecd to its active form, 20-hydroxyecdysone, by the cytochrome P450 enzyme Shade, together with enterocyte Ecd receptor activity, is required for Lp-dependent intestinal and systemic growth. Pharmacological activation of Ecd signaling partially mimicked the bacterial effect, confirming its sufficiency to drive adaptive midgut expansion. Our results uncover an unexpected role of intestinal Ecd signaling in microbiota-driven developmental plasticity, revealing how commensal bacteria modulate local steroid signaling to fine-tune organismal growth and maturation.


  • Open Access

    Symbiosis through lysis: host-triggered prophage induction drives probiotic function in Lactiplantibacillus plantarum

    by C Zhu, S Manuse, Q Perrier, S Venkatasubramaniyan, H Akherraz, N Lodej, Ci Ramos, M Zhang, C Grangeasse, A Razim, et al.

    The release of bacterial bioactive molecules across the gut barrier is a crucial yet poorly understood step in microbe-host molecular dialog. Here we unravel a phage-driven mechanism that enables this process in a symbiont that supports host adaptive growth. In Lactiplantibacillus plantarum NC8 ( Lp NC8 ), we identify a stress-inducible prophage, pp2, that undergoes genotoxic-stress-dependent activation in vivo and triggers holin-lysin-mediated lysis. This controlled lytic program produces phage particles together with extracellular vesicles (EVs), enriched in symbiotic cues, including lipoteichoic acids. In a model of beneficial symbiosis, pp2-dependent lysis is strictly required for the ability of Lp NC8 to support juvenile growth in nutritionally challenged Drosophila melanogaster . Disruption of pp2-dependent lysis abolishes EVs release in vitro and alters the growth-promoting effect in vivo . We show that the acidic region of the Drosophila midgut, but not host antimicrobial peptides nor lysozymes, acts as a physiological trigger of prophage induction: removal of this acidic compartment markedly reduces phage production and impairs Lp NC8 -mediated growth promotion. These findings demonstrate that host gut physiology regulates prophage activation and reveal prophage-induced lysis as a previously unrecognized mechanism by which a beneficial gut bacterium releases symbiotic cues to support host development during nutritional stress.

  • Open Access

    A nutrient-sensitive enterokine coordinates developmental plasticity through inter-organ signalling

    by L Bai, J Montagne, Ci Ramos, F Leulier

    Animal survival in fluctuating environments depends on the ability to modulate their developmental pace in response to nutrient availability, a phenomenon known as developmental plasticity. In Drosophila larvae, we uncover a critical endocrine mechanism that coordinates this process under conditions of amino acid restriction. We identify the peptide hormone Limostatin as an enterokine, produced by a small population of larval midgut enteroendocrine cells, that acts systemically to inhibit the expression and release of dIlp2, a major insulin-like peptide controlling developmental progression. Limostatin expression and secretion by enteroendocrine cells is triggered by reduced amino acid availability through an inter-organ relay involving the fat body and neuroendocrine insulin-producing cells in the brain. In turn, Limostatin participates in a feedback control loop that slows down developmental progression once systemic nutrient shortage is sensed. This bidirectional gut-brain axis enables larvae to preserve viability under nutritional stress. Our findings define the larval gut as a nutrient-sensitive endocrine organ and position Limostatin as a key regulator of developmental plasticity. Our work expands the concept of decretins to include developmental pace control, suggesting that enterokines that regulate IGF signalling, rather than insulin release per se, may represent an evolutionarily conserved or convergent strategy in regulating developmental plasticity.

  • Open Access

    Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile Male Mice via Reduced Energy Metabolism

    by Amélie Joly, Lucas Rebiffé, Yves Dusabyinema, Julien Dellinger, Estelle Caillon, Karine Gauthier, François Leulier, Filipe De Vadder

    Animals rely on linear growth to attain their full adult size. The regulators of this multifactorial process, including environmental and endocrine cues, are still incompletely understood. Notably, GLP-1, glucagon-like peptide 1 (GLP-1) has emerged as a potential player in this process. Here, we employ semaglutide, a pharmaceutical GLP-1R agonist as a tool to mechanistically dissect the interplay between GLP-1 receptor activation, energy metabolism, and linear growth during the juvenile period, independent of its clinical applications. Using a juvenile mouse model, we show that chronic semaglutide treatment lowers blood glucose without affecting food intake or weight gain in juveniles with a normal growth pattern. However, in growth-stunted juveniles, semaglutide treatment exacerbates linear growth impairment through at least 2 concomitant mechanisms: a moderate reduction in food intake, and a decreased catabolic activity incompatible with tissue growth. These data suggest a complex interplay between GLP-1 signaling, energy metabolism, and growth during juvenile development. Overall, these findings highlight the value of semaglutide as a mechanistic tool for understanding how GLP-1 receptor activation modulates growth and metabolism in juveniles, emphasizing the importance of developmental context for interpreting its effects.